tradingkey.logo

Zimmer Biomet Holdings Inc

ZBH
90.805USD
+0.275+0.30%
Fechamento 12/30, 16:00ETCotações atrasadas em 15 min
18.00BValor de mercado
22.40P/L TTM

Zimmer Biomet Holdings Inc

90.805
+0.275+0.30%

Mais detalhes de Zimmer Biomet Holdings Inc Empresa

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.

Informações de Zimmer Biomet Holdings Inc

Código da empresaZBH
Nome da EmpresaZimmer Biomet Holdings Inc
Data de listagemJul 25, 2001
CEOTornos (Ivan)
Número de funcionários17000
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 25
Endereço345 E Main St
CidadeWARSAW
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal46580-2746
Telefone15742676131
Sitehttps://www.zimmerbiomet.com/en
Código da empresaZBH
Data de listagemJul 25, 2001
CEOTornos (Ivan)

Executivos da empresa Zimmer Biomet Holdings Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
54.75K
+12.08%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
--
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
3.42K
+34.66%
Mr. Arthur J. (Art) Higgins
Mr. Arthur J. (Art) Higgins
Independent Director
Independent Director
3.40K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
54.75K
+12.08%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
--
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%
Por RegiãoUSD
Nome
Receita
Proporção
United States
1.17B
56.51%
International
903.50M
43.49%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%

Distribuição de ações

Atualizado em: seg, 17 de nov
Atualizado em: seg, 17 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Dodge & Cox
11.71%
The Vanguard Group, Inc.
11.70%
T. Rowe Price Associates, Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
5.58%
State Street Investment Management (US)
4.36%
Outro
59.19%
Investidores
Investidores
Proporção
Dodge & Cox
11.71%
The Vanguard Group, Inc.
11.70%
T. Rowe Price Associates, Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
5.58%
State Street Investment Management (US)
4.36%
Outro
59.19%
Tipos de investidores
Investidores
Proporção
Investment Advisor
54.12%
Investment Advisor/Hedge Fund
37.70%
Hedge Fund
2.18%
Pension Fund
2.06%
Research Firm
1.73%
Bank and Trust
1.28%
Sovereign Wealth Fund
1.27%
Individual Investor
0.13%
Family Office
0.07%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
1945
195.45M
98.66%
-607.37K
2025Q2
1996
190.39M
96.22%
-5.04M
2025Q1
2047
189.51M
95.78%
-9.49M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
2023Q4
1991
188.03M
89.99%
-18.28M
2023Q3
1984
188.24M
90.09%
-20.30M
2023Q2
2003
190.89M
91.52%
-16.92M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dodge & Cox
22.10M
11.15%
+2.01M
+10.01%
Jun 30, 2025
The Vanguard Group, Inc.
23.16M
11.69%
+196.58K
+0.86%
Jun 30, 2025
T. Rowe Price Associates, Inc.
14.50M
7.32%
+336.36K
+2.37%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
10.93M
5.52%
-195.19K
-1.75%
Jun 30, 2025
State Street Investment Management (US)
8.75M
4.42%
-6.59K
-0.08%
Jun 30, 2025
Capital International Investors
6.77M
3.42%
+6.77M
--
Jun 30, 2025
Geode Capital Management, L.L.C.
5.12M
2.59%
+69.48K
+1.37%
Jun 30, 2025
American Century Investment Management, Inc.
5.71M
2.88%
+458.90K
+8.74%
Jun 30, 2025
Harris Associates L.P.
3.73M
1.88%
+3.73M
--
Jun 30, 2025
PRIMECAP Management Company
4.71M
2.38%
+27.86K
+0.59%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Langar Global HealthTech ETF
4.98%
VanEck Morningstar Wide Moat Value ETF
4.58%
Leatherback Long/Short Alternative Yield ETF
2.9%
VanEck Morningstar Wide Moat ETF
2.46%
iShares U.S. Medical Devices ETF
2.37%
First Trust Indxx Medical Devices ETF
2.13%
American Century Focused Large Cap Value ETF
2.03%
Invesco Raymond James SB-1 Equity ETF
1.87%
First Trust Health Care Alphadex Fund
1.78%
State Street SPDR S&P Health Care Equipment ETF
1.75%
Ver Mais
Langar Global HealthTech ETF
Proporção4.98%
VanEck Morningstar Wide Moat Value ETF
Proporção4.58%
Leatherback Long/Short Alternative Yield ETF
Proporção2.9%
VanEck Morningstar Wide Moat ETF
Proporção2.46%
iShares U.S. Medical Devices ETF
Proporção2.37%
First Trust Indxx Medical Devices ETF
Proporção2.13%
American Century Focused Large Cap Value ETF
Proporção2.03%
Invesco Raymond James SB-1 Equity ETF
Proporção1.87%
First Trust Health Care Alphadex Fund
Proporção1.78%
State Street SPDR S&P Health Care Equipment ETF
Proporção1.75%

Dividendo

Um total de 996.70M USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Dec 17, 2025
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 30, 2026 going ex on Dec 30, 2025 with reinvestment option
Dec 30, 2025
Jan 30, 2026
Dec 30, 2025
Aug 27, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2025 going ex on Sep 30, 2025 with reinvestment option
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 30, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2025 going ex on Jun 26, 2025
Jun 26, 2025
Jul 31, 2025
Jun 26, 2025
Feb 26, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024 with reinvestment option
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 14, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 31, 2024
Dec 26, 2023
Ver Mais

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados

Perguntas frequentes

Quem são os cinco principais acionistas de Zimmer Biomet Holdings Inc?

Os cinco principais acionistas de Zimmer Biomet Holdings Inc são:
Dodge & Cox detém 22.10M Ações, representando 11.15% do total de Ações.
The Vanguard Group, Inc. detém 23.16M Ações, representando 11.69% do total de Ações.
T. Rowe Price Associates, Inc. detém 14.50M Ações, representando 7.32% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 10.93M Ações, representando 5.52% do total de Ações.
State Street Investment Management (US) detém 8.75M Ações, representando 4.42% do total de Ações.

Quais são os três principais tipos de acionistas de Zimmer Biomet Holdings Inc?

Os três principais tipos de acionistas da Zimmer Biomet Holdings Inc são:
Dodge & Cox
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.

Quantas instituições possuem ações da Zimmer Biomet Holdings Inc (ZBH)?

Em 2025Q3, 1945 instituições possuíam ações da Zimmer Biomet Holdings Inc, com valor de mercado aproximado de 195.45M, representando 98.66% do total de ações. Em comparação com 2025Q2, a participação institucional aumentou em 2.44%.

Qual é a maior fonte de receita da Zimmer Biomet Holdings Inc?

Em FY2025Q2, o segmento de negócios Knees gerou a maior receita para Zimmer Biomet Holdings Inc, totalizando 826.00M e representando 39.76% da receita total.
KeyAI